The survival rate of cancer patients is steadily increasing, owing to more efficient therapies. Understanding the molecular mechanisms of chemotherapy-induced premature ovarian insufficiency (POI) could identify targets for prevention of POI. Loss of the primordial follicle reserve is the most important cause of POI, with the p53 family member p63 being responsible for DNA-damage-induced apoptosis of resting oocytes. Here, we provide the first detailed mechanistic insight into the activation of p63, a process that requires phosphorylation by both the priming kinase CHK2 and the executioner kinase CK1 in mouse primordial follicles. We further describe the structural changes induced by phosphorylation that enable p63 to adopt its active tetrameric conformation and demonstrate that previously discussed phosphorylation by c-Abl is not involved in this process. Inhibition of CK1 rescues primary oocytes from doxorubicin and cisplatin-induced apoptosis, thus uncovering a new target for the development of fertoprotective therapies.

Tuppi, M., Kehrloesser, S., Coutandin, D.w., Rossi, V., Luh, L.m., Strubel, A., et al. (2018). Oocyte DNA damage quality control requires consecutive interplay of CHK2 and CK1 to activate p63. NATURE STRUCTURAL & MOLECULAR BIOLOGY [10.1038/s41594-018-0035-7].

Oocyte DNA damage quality control requires consecutive interplay of CHK2 and CK1 to activate p63

Rossi, Valerio;De Felici, Massimo;Klinger, Francesca Gioia;
2018-01-01

Abstract

The survival rate of cancer patients is steadily increasing, owing to more efficient therapies. Understanding the molecular mechanisms of chemotherapy-induced premature ovarian insufficiency (POI) could identify targets for prevention of POI. Loss of the primordial follicle reserve is the most important cause of POI, with the p53 family member p63 being responsible for DNA-damage-induced apoptosis of resting oocytes. Here, we provide the first detailed mechanistic insight into the activation of p63, a process that requires phosphorylation by both the priming kinase CHK2 and the executioner kinase CK1 in mouse primordial follicles. We further describe the structural changes induced by phosphorylation that enable p63 to adopt its active tetrameric conformation and demonstrate that previously discussed phosphorylation by c-Abl is not involved in this process. Inhibition of CK1 rescues primary oocytes from doxorubicin and cisplatin-induced apoptosis, thus uncovering a new target for the development of fertoprotective therapies.
Online ahead of print
Rilevanza internazionale
Articolo
Esperti anonimi
Settore BIO/17
Settore BIO/10
Settore BIO/11
Settore BIO/13
English
Con Impact Factor ISI
Tuppi, M., Kehrloesser, S., Coutandin, D.w., Rossi, V., Luh, L.m., Strubel, A., et al. (2018). Oocyte DNA damage quality control requires consecutive interplay of CHK2 and CK1 to activate p63. NATURE STRUCTURAL & MOLECULAR BIOLOGY [10.1038/s41594-018-0035-7].
Tuppi, M; Kehrloesser, S; Coutandin, Dw; Rossi, V; Luh, Lm; Strubel, A; Hötte, K; Hoffmeister, M; Schäfer, B; De Oliveira, T; Greten, F; Stelzer, Ehk; Knapp, S; De Felici, M; Behrends, C; Klinger, Fg; Dötsch, V
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
Tuppi et al 2018.pdf

accesso solo dalla rete interna

Licenza: Copyright dell'editore
Dimensione 5.05 MB
Formato Adobe PDF
5.05 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/194398
Citazioni
  • ???jsp.display-item.citation.pmc??? 53
  • Scopus 73
  • ???jsp.display-item.citation.isi??? 76
social impact